Other Comparison

Cerluten vs Selank

Comparison of Cerluten (Low evidence) and Selank (Moderate evidence).

Last updated: February 12, 2026

Cerluten

Low Evidence
View full dossier

Selank

Moderate Evidence
View full dossier

Overview

Cerluten and Selank are both studied in the peptide research space.

Cerluten: A cytamin-class peptide supplement derived from brain tissue, part of the Russian bioregulator framework.

Selank: A synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed by Russian researchers and approved in Russia since 2009 for anxiety and neurasthenia.

Evidence Comparison

AspectCerlutenSelank
Evidence LevelLowModerate
Human Studies15
Preclinical Studies620
Total Sources825

Key Differences

AspectCerlutenSelank
CategoryCognitiveCognitive
Evidence StrengthLowModerate
Total Sources825
Human Studies15

Summary

  • Cerluten: Low evidence with 8 total sources (1 human)
  • Selank: Moderate evidence with 25 total sources (5 human)

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.

Stay Updated on Peptide Comparisons

Get notified when we publish new comparison dossiers and evidence reviews.

No spam. Unsubscribe anytime.

Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.